Regulating the pharmaceutical industry. Authors seem to have misunderstood pharmaceutical price regulation scheme.
作者信息
Read P
出版信息
BMJ. 1998 Jan 17;316(7126):226; author reply 228.
Abstract
摘要
相似文献
1
Regulating the pharmaceutical industry. Authors seem to have misunderstood pharmaceutical price regulation scheme.
BMJ. 1998 Jan 17;316(7126):226; author reply 228.
2
Time to fix the price fix.
Health Serv J. 1997 Nov 6;107(5578):22-3.
3
Regulating the pharmaceutical industry. Regulation may no longer be necessary.
BMJ. 1998 Jan 17;316(7126):227; author reply 228.
4
The pharmaceutical price regulation scheme.
BMJ. 2007 Mar 3;334(7591):435-6. doi: 10.1136/bmj.39136.464421.BE.
5
NHS spending on drugs is frozen for two years under price deal.
BMJ. 2013 Nov 7;347:f6731. doi: 10.1136/bmj.f6731.
6
Pharma focus. Market traders.
Health Serv J. 2003 Nov 27;113(5883):suppl 2-3.
7
International pharmaceutical spending controls: France, Germany, Sweden, and the United Kingdom.
Health Care Financ Rev. 1994 Spring;15(3):127-40.
8
New drug pricing scheme could politicise decisions and reduce access, says think tank.
BMJ. 2013 May 8;346:f2965. doi: 10.1136/bmj.f2965.
9
The UK pharmaceutical market. An overview.
Pharmacoeconomics. 1996;10 Suppl 2:14-25. doi: 10.2165/00019053-199600102-00005.
10
Pharmaceuticals. Plunder and pillage.
Health Serv J. 1999 May 6;109(5653):18-20.
引用本文的文献
1
The need for pharmacoeconomic evaluations in the NHS.
Pharmacoeconomics. 1998 Sep;14(3):241-50. doi: 10.2165/00019053-199814030-00001.
Zotero 插件